Dr. Richard L. White Jr.

• 
  www.givechf.org/index.php?option=com_content&task=view& - [Cached Version]
  Published on: 7/24/2008    Last Visited: 7/24/2008  

  (Top: L-R) Michael Kreshon; Martin Kreshon, Jr., M.D.; John Kreshon; and Martin Kreshon, Sr., M.D. tee it up to for Save Your Skin. (Bottom: L-R) John Teague, Client Advisory Services, Columbia Management, and Martin Kreshon, Sr., M.D., present a check to Richard White, M.D., co-director of the Immunotherapy Program at Blumenthal Cancer Center.
  ...
  Funds raised will help boost Blumenthal Cancer Center's Immunotherapy Program, co-directed by Richard L. White, Jr., M.D and Asim Amin, M.D.

• 
  www.btfcnc.org/regional-research-partnership/uncc-affil - [Cached Version]
  Published on: 4/4/2007    Last Visited: 4/4/2007  

  Dr. Dreau will partner with Charlotte doctors Richard White of Carolinas Medical Center, James Dollar of Carolinas Pathology Group, Stuart Burri and William Warlick of Southeast Radiation Oncology Group, and Tony Asher of Carolina Neurosurgery & Spine Associates.

• 
  www.sesc.org/ASM/Previous/2004/2004MeetingHighlights.ht - [Cached Version]
  Published on: 1/1/2004    Last Visited: 3/24/2007  

  Update on the NSABP and ACOSOG Sentinel Node Trials Richard L. White, Jr., MD, Carolinas Medical Center, Charlotte, NC
  
  Management of Women at High Risk of Developing Breast Cancer

• 
  www.givechf.org/index.php?option=com_content&task=view& - [Cached Version]
  Published on: 5/27/2008    Last Visited: 5/27/2008  

  The event raised more than $2,400 for the Carolinas Melanoma and Immunotherapy Fund at CMC, which supports treatment, research, and outreach prevention programs under the direction of Richard L. White, Jr., M.D.

• 
  www.givechf.org/index.php?option=com_content&task=view& - [Cached Version]
  Published on: 3/24/2008    Last Visited: 3/24/2008  

  Funds raised will help boost Blumenthal Cancer Center's Immunotherapy Program, co-directed by Richard L. White,Jr., M.D.

• 
  www.givechf.org/index.php?option=com_content&task=view& - [Cached Version]
  Published on: 3/24/2008    Last Visited: 3/24/2008  

  Directed by Richard L. White, M.D., the Immunotherapy Program features both inpatient and outpatient treatment services and a scientific research laboratory at the James G. Cannon Research Center, adjacent to CMC.
  
  "We are excited about the strong community support for the Immunotherapy Program and our ongoing research into effective treatments for advanced melanoma," said Dr. White.

• 
  www.givechf.org/newssandpress-news-article.cfm?art_id=4 - [Cached Version]
  Published on: 9/14/2006    Last Visited: 12/6/2007  

  The event raised $2,500 for the Carolinas Melanoma and Immunotherapy Fund at Carolinas Medical Center (CMC), which supports treatment, research, and outreach programs under the direction of Richard L. White, Jr., M.D.

• 
  www.givechf.org/newssandpress-news-article.cfm?art_id=3 - [Cached Version]
  Published on: 9/14/2006    Last Visited: 11/15/2007  

  Under the direction of Richard L. White, Jr., MD, and Charles H. Packman, MD the program will seek to increase cancer awareness and education, negotiate transportation and offer emotional support and guidance for medically underserved women in our community.

• 
  Brain Tumor Fund for the Carolinas (BTFC) - Charlotte... - [Cached Version]
  Published on: 4/4/2007    Last Visited: 6/28/2008  

  Richard L. White, M.D.Chief, Division of Surgical OncologyDept of General SurgeryCarolinas Medical Center1000 Blythe Blvd.Charlotte, NC 28232
  
  Tel: 704 355 3809Fax: 704 355 7473
  ...
  Asher, White, Burri, and Dollars have years of experience in the clinical area including the development of research protocols involving patients specimens.

• 
  Breast Cancer News Article - [Cached Version]
  Published on: 12/26/1999    Last Visited: 3/12/2001  

  That's why this matters , said Dr. Richard White , a Carolinas Medical Center surgeon who has performed nearly 50 sentinel node biopsies.
  
  Many of our treatment decisions are based on that.If you get the wrong information , you potentially are doing harm..
  
  ...
  In melanoma , if the sentinel nodes are negative , the likelihood of there being cancer in other nodes is less than 1 percent , according to White.If the sentinel nodes are positive , the likelihood of spread is 20 percent to 30 percent.
  
  Because of the success with melanoma , researchers are now evaluating the use of sentinel node biopsy in other tumors , such as breast and thyroid cancer.
  
  Here is how it works :.
  
  ...
  White , who has co-written a textbook chapter on sentinel node biopsy , said early evidence suggests that the procedure accurately predicts whether the cancer has spread , but that's not certain.
  
  The procedure is difficult to do , and even proficient surgeons can get false negatives.In one study published in the New England Journal of Medicine in 1998 , one in 10 patients with cancer-free sentinel nodes was found to have cancer in other underarm nodes.
  
  If you don't take out the rest of the nodes ( to compare them to the sentinel nodes ) , you don't know what your false negative rate is , White said.
  
  It may turn out that this will be a better technique in the right hands but it's not `Zim-bang , we've got a new thing , everybody should go and get this.'.

Page:  1 2 3